Vitranu, Inc.

COLUMBUS, OH · Founded 2020 · CIK 0001890125 · Medtech · Private

Tunable extended-release capsule technology for sustained drug delivery

vitranu.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.5M
1 Form D · Oct 2021
59 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,511,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1417Thrive Bioscience, Inc.—$14M
1418ENVIROMETRIX INSTRUMENTS, LLC——
1419RAMONA OPTICS, INC.—$28M
1420Vitranu, Inc.—$1.5M
1421Ozette Technologies, Inc.—$5.8M
1422NEOVIEW, INC.——
1423BIOCREDE INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Brad BeaseckerExecutive Officer
  • Gordon BethwaiteDirector · Executive Officer
  • Gary CharbonneauDirector
  • Wayne EmbreeDirector
  • Robin SearsDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.